IHI, the new public-private partnership that replaces IMI, has published a list of tentative themes that could be included in the following calls, which are planned to open at the end of 2022 and the beginning of 2023.

Please note that these topics are still under discussion and they may change considerably between now and the call launch.

IHI call 3 (Single stage call):

- Topic 1: Screening platform and biomarkers for prediction and prevention of diseases of unmet public health need
- Topic 2: Patient generated evidence to improve outcomes, support decision making, and accelerate innovation
- Topic 3: Combining hospital interventional approaches to improve patient outcomes and increase hospital efficiencies
- Topic 4: Strengthening the European ecosystem for Advanced Therapy Medicinal Products (ATMPs) and other innovative therapeutic modalities for rare diseases
- Topic 5: Digital health technologies for the prevention and personalised management of mental disorders and their long-term health consequences

IHI call 4 (Two stage call):

- Topic 1: Expanding translational knowledge in minipigs: a path to reduce and replace non-human primates in non-clinical drug safety assessment
- Topic 2: Patient-centric blood sample collection to enable decentralised clinical trials and improve access to healthcare

Currently, the draft topics are under consultation with IHI’s States Representatives Group and Science and Innovation Panel. It is therefore likely that the topics may change considerably between now and the call launch,

More information: https://www.ihi.europa.eu/apply-funding/future-opportunities

(You can find all news related to Horizon Europe in the banner “Horizon Europe” at IMIM’s intranet)